通过中介组织、预防研究中心与疫苗信心网络应对COVID-19疫苗公平的策略
2021年4月,美国CDC向全部26个预防研究中心(PRC)提供补充资金,建立PRC疫苗信心网络(VCN),以提升受COVID-19影响严重社区及疫苗犹豫人群的疫苗信心与接种。文章描述康涅狄格、得克萨斯和华盛顿三个VCN-PRC-中介组织合作案例,探讨中介组织在社区主导公共卫生行动中的作用及经验教训。
要点
- CDC于2021年4月向全部26个PRC提供补充资金建立VCN。
- 中介组织是共同信任的社区和实践型组织,开展社区外展和干预活动。
- 中介组织有助于建立社区信任、回应社区需求,提升疫苗信心和需求。
核心结论
- 与中介组织合作有助于实现VCN目标,中介组织在建立社区信任、回应社区需求以及提升受疫情影响严重地区和社区的疫苗信心与需求方面发挥关键作用。
- 文章分享VCN-PRC-中介组织合作的经验教训,并讨论其如何适用于当前和未来的疫苗接种与外展。
研究设计与样本
- 文章描述康涅狄格(Yale-Griffin)、得克萨斯(University of Texas Health Houston, UTHealth Houston)和华盛顿(University of Washington Health Promotion Research Center, UW HPRC)三个VCN-PRC-中介组织合作案例,作为疫苗干预模型。
- CDC于2021年4月向全部26个预防研究中心(PRC)提供补充资金,建立PRC疫苗信心网络(VCN)。
主要发现
- 中介组织是相互信任的社区和实践型组织,开展社区外展和干预活动,以解决共同关注社区的障碍。
- 中介组织在建立社区信任、回应社区需求和关切,进而提升受疫情影响严重地区和社区的疫苗信心与需求方面发挥关键作用。
- CDC COVID-19响应疫苗工作组在组建VCN中发挥作用,支持信息、资源和策略的及时交流。
临床怎么用
- 文章将三个VCN-PRC-中介组织合作案例作为疫苗干预模型进行描述。
- 文章讨论中介组织合作在实施社区主导公共卫生行动以提升COVID-19大流行期间疫苗信任和可及性方面的重要性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In April 2021, the CDC provided supplemental funding to all 26 Prevention Research Centers (PRCs) to create the PRC Vaccine Confidence Network (VCN) to increase COVID-19 vaccine confidence and uptake in communities disparately impacted by COVID-19 and/or in vaccine hesitant populations. A key strategy to building vaccine confidence was engaging with intermediaries (i.e., mutually trusted community and practice-based organizations conducting community outreach and intervention activities) to address barriers for our shared communities of focus. These intermediaries were key in building community trust, addressing community needs and concerns, and in turn, building vaccine confidence and demand in areas and communities disproportionately affected by the pandemic. While engaging with intermediaries helped to achieve the goals of the VCN, the role of intermediaries has not been consistently and widely described in the health promotion and disease prevention literature. In this manuscript we describe three cases of VCN-PRC-intermediary collaboration in Connecticut (Yale-Griffin), Texas (University of Texas Health Houston, UTHealth Houston), and Washington (University of Washington Health Promotion Research Center, UW HPRC) during the COVID-19 pandemic as a model for vaccine intervention. We discuss the importance of intermediary collaboration in implementing community-led public health actions to increase vaccine trust and access during the COVID-19 pandemic. We describe the role of the CDC COVID-19 Response Vaccine Task Force in forming the VCN, which supported timely exchanges of information, resources, and strategies. Finally, we share lessons learned from the VCN-PRC-intermediary collaborations and how they may apply to current and future vaccine uptake and outreach.
引用
- Hara-Hubbard KK, Beaulieu A, Mendiola A, et al. Strategies for addressing COVID-19 vaccine equity with intermediaries, prevention research centers, and the vaccine confidence network. Vaccine. 2025. PMID: 41101080. doi:10.1016/j.vaccine.2025.127847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。